About
Enzymotec was built on a specific technical bet: that enzymatic processing could produce lipids that were better — and more precisely defined — than conventional chemistry allowed. Founded in 1999 at the Naiot Venture Accelerator in Migdal HaEmek, the company turned that bet into ingredients for some of the most demanding nutritional markets. Its products are structured lipids, nutritional oils, phospholipids and enzymatic bio-actives, made from natural sources such as fish and plant oils. The company pioneered industrial enzymatic processing, using enzymatic transesterification, lipid fractionation and biocatalysis to create high-value lipids. Infant nutrition — premium lipids for formula — is a core market, alongside clinical nutrition, medical food and supplements. Its InFat and Sharp PS lines are recognized ingredients in global infant and clinical nutrition. Since 2017 the business has been part of the Frutarom/IFF group, which brought global supply and compliance support to an operation that had grown up as a specialist. Its customers are infant formula makers, clinical nutrition and supplement brands, and food manufacturers. Because these ingredients sit inside regulated nutrition products, an enquiry should state the lipid type, the purity required, the application and the regulatory framework the buyer is working within.
Also known as: Enzymotec Ltd, Enzymotec
Company Facts
- Founded
- 1999
- Headquarters
- Migdal HaEmek, Israel
- Former Listing
- NASDAQ Global Market
- Acquired By
- Frutarom (2017), later part of IFF
- Industry
- Specialty Lipids & Bio-Ingredients
- Business Type
- Manufacturer & Technology Company
- Employees
- 200+
- Main Products
- Specialty lipids, enzymatic ingredients, structured lipids
- Core Technology
- Enzymatic lipid processing
- Certifications
- ISO 9001, ISO 22000, FSSC 22000, GMP, Kosher, Halal
Frequently Asked Questions
What did Enzymotec produce?+
Enzymotec produced specialty lipids and enzymatic ingredients, including structured lipids, nutritional oils and phospholipids, for infant nutrition, supplements and functional foods.
What technology did Enzymotec use?+
Enzymotec specialized in enzymatic processing technologies that enable production of high-purity, tailored lipid and bio-active molecules.
Who acquired Enzymotec?+
Enzymotec was acquired by Frutarom in 2017 and later became part of IFF following IFF's acquisition of Frutarom in 2018.
Where was Enzymotec located?+
Enzymotec was based in Migdal HaEmek, in northern Israel.
Was Enzymotec publicly traded?+
Yes. Enzymotec was listed on the NASDAQ Global Market before its acquisition.
Top Products
Structured Lipids
Tailored lipid molecules produced enzymatically for infant nutrition and clinical applications.
MOQ: 100 kg
Nutritional Oils
Specialty oils rich in specific fatty acids for dietary supplements and functional foods.
MOQ: 100 kg
Phospholipids
High-purity phospholipid ingredients for nutrition and pharmaceutical applications.
MOQ: 100 kg
Enzymatic Bio-Actives
Bio-active ingredients produced via enzymatic processing for health and wellness products.
MOQ: 50 kg